Vimian Group has signed an agreement to acquire Kahu Vet Group (“Kahuvet”), a New Zealand-based supplier of veterinary products in New Zealand and Australia.
Kahuvet will join Movora, the MedTech division of Vimian, and bring excellent customer service, efficient distribution, and extensive knowledge of the veterinary industry to customers in the Oceania region.
Established in 2010, the company has a broad offering of veterinary orthopedic implants, surgical instruments, equipment as well pharmaceuticals and consumables. Most products are sold under Kahuvet’s own brand, Knight Benedikt, to more than 700 veterinary clinics in New Zealand and Australia, with plans to extend the innovative Movora product portfolio in its entirety.
In addition, Kahuvet offers training for advanced surgical procedures in its own educational center.
“Through Kahuvet we gain a strong local footprint and a can offer our full MedTech product portfolio locally with improved customer service, shorter delivery times and a more efficient supply chain. Kahuvet is a fast-growing company and we’re excited to work together with this commercially driven team,” says Guy Spörri, Co-CEO of Movora.
Please join us in welcoming Kahuvet to Movora. We are looking forward to accelerating our growth in Australia and New Zealand together.
For further information, please contact
[email protected]
+1 904.436.6540
About Movora
Movora is a global provider of orthopedic implants sold to veterinarians, veterinary surgeons, and universities. Through its brands, BioMedtrix, KYON, and Veterinary Orthopedic Implants, it offers one of the broadest product portfolios within companion animal orthopedics, ranging from fracture plates to complete hip replacement systems. Movora also believes in supporting veterinary professionals throughout their careers and offers one of the most comprehensive calendars of Continuing Education courses in the industry, teaching DVMs and Veterinary Surgeons new techniques and procedures. Movora has regional headquarters in Florida, USA; Ontario, Canada; Zurich, Switzerland; and Tokyo, Japan. Learn more by visiting www.movora.com.
About Vimian
Vimian is a global, fast-growing group of innovation-driven companies with a shared passion for making a positive impact through improving animal health. Together, we put science, technology and our customers’ needs at the centre of everything we do to deliver effective solutions to veterinary professionals, labs and pet parents around the world. We bring together pioneering and entrepreneurial businesses in animal health, with an aim to create a uniquely diversified proposition of products and services of the highest standard. Our group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to our networks, expertise, infrastructure and capital to accelerate innovation and growth. We are as passionate about supporting leadership within our existing businesses, as we are about welcoming new partners to the Vimian family – together helping us make an even greater impact by improving animal health. Headquartered in Stockholm, Sweden, Vimian and our family of companies reach over 15,000 customers in +150 markets, employ more than 450 people and have a combined annual turnover of approximately EUR 140 million. FNCA Sweden AB is appointed the Company’s Certified Adviser, [email protected], +46 (0) 8-528 00 399. For more information, please visit: www.vimian.com.
For more information about Vimian:
Maria Dahllöf Tullberg
Head of IR & Communications, Vimian
[email protected]
+46 736 26 88 86
